NUTRA PHARMA CORP (NPHC) › Operating IncomeNUTRA PHARMA CORP (NPHC) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2010: -$3.40M2011: -$3.95M2012: -$2.60M2013: -$2.36M2014: -$2.20M2015: -$5.77M2016: -$2.04M2017: -$1.38M2018: -$1.88M2019: -$1.23M2020: -$924.9K2021: -$1.99M2022: -$1.91M2023: -$887.0K2024: -$878.4K2025: -$1.46M-$1.46M2010Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$1.46M-66.5%2024-$878.4K+1.0%2023-$887.0K+53.5%2022-$1.91M+4.1%2021-$1.99M-115.0%2020-$924.9K+24.8%2019-$1.23M+34.5%2018-$1.88M-36.0%2017-$1.38M+32.4%2016-$2.04M+64.6%2015-$5.77M-161.8%2014-$2.20M+6.7%2013-$2.36M+9.2%2012-$2.60M+34.2%2011-$3.95M-16.3%2010-$3.40M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share